China is using economic leverage to dominate the global supply chain for medicines, and the U.S. must take action to protect its leadership in the biomedical industry by strengthening regulatory frameworks and investing in domestic infrastructure.
China is using economic leverage to dominate the global supply chain for medicines, and the U.S. must take action to protect its leadership in the biomedical industry by strengthening regulatory frameworks and investing in domestic infrastructure.
<iframe src="https://statesidedaily.com/embed/cluster/d29a59179f463eef22ac60bbeff1da56a8bae2dc" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="China is quietly taking control of US medicine. We must stop helping it."></iframe>
